The MarketWatch News Department was not involved in the creation of this content. -- UK Market Entry: MHRA registration authorizes hp+detect(TM) for commercial sale in Great Britain -- Active ...
UK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great Britain Active Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic ...
Active Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic laboratory market and expects to provide further updates as agreements are finalized. Disease ...
Registration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across Europe’s five largest countries Source: Biomerica, Inc. The views and ...
Registration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across Europe’s five largest countries IRVINE, Calif., March 05, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results